American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead Story: HBCD Study Will Answer Important Questions about Substance Use in Pregnancy

Lead Story: HBCD Study Will Answer Important Questions about Substance Use in Pregnancy

Tuesday 21st June 2022

Discover how brain lesions affect addiction and learn about racial disparities in treatment on 'This Week in Addiction Medicine'.
6 minutes
Informative
Educational
Engaging
Transformative
Motivational

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Brain Lesions and Addiction: Unveiling New Treatment Targets

The study found that lesions that disrupted smoking addiction occurred in many different brain locations but were characterized by a specific pattern of brain connectivity. These results were reproducible across independent lesion cohorts and were associated with reduced alcohol addiction risk.
Ever wondered how brain lesions might affect addiction? This episode of 'This Week in Addiction Medicine' dives into a fascinating study published in Nature Medicine that explores this very question. The research analyzed patients addicted to smoking who experienced focal brain damage, uncovering a specific pattern of brain connectivity linked to addiction remission. This discovery could pave the way for new therapeutic targets for neuromodulation, offering hope for those battling addiction. But that's just the beginning.
The episode also sheds light on a study examining racial and ethnic disparities in buprenorphine and extended-release naltrexone prescriptions during the COVID pandemic. Alarmingly, it found significant decreases in prescription fills for Black, Hispanic, and Asian patients, while white patients saw no such decline. Additionally, listeners will learn about hyperkatifeia, a condition marked by heightened negative emotional symptoms during withdrawal from alcohol and drugs.
The podcast also covers binge drinking among moderate drinkers, revealing its strong link to multiple alcohol problems both immediately and years later. For those interested in jail-based treatment for opioid use disorder, there's a qualitative study featuring interviews with staff at New Jersey county jails about their current practices. Lastly, the episode delves into the effectiveness of cannabis-based products for chronic pain.
While synthetic products with high THC to CBD ratios showed moderate pain relief, they also increased sedation and dizziness. Products with balanced THC to CBD ratios offered slight pain improvement but came with a higher risk of sedation and nausea. Whether you're a healthcare professional, someone affected by addiction, or just curious about the latest in addiction medicine, this episode is packed with valuable insights.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.